3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Stomach Neoplasms
1
Psychological Well-Being
1
Pancreatic Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Liver Neoplasms
1
Leiomyoma
1
Inflammation
1
Esophageal Neoplasms
1
Carcinoma, Hepatocellular
1
Agnosia
1
Abdominal Cancer
1
Interventions
Tea
1
Sufentanil
1
Morphine
1
Ketorolac
1
Ibuprofen
1
Anti-Inflammatory Agents, Non-Steroidal
1
Analgesia, Patient-Controlled
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Inflammation
×
Tea
×
Clear all
NCT01367418
2012-03-19
AIMS
Örebro University, Sweden
Phase 3
Completed
26 enrolled